
2025-11-04 11:59:34
¿ÆÑ§¼ÒÕ¹ÏÖhPSCÑÜÉúµÄÊ©Íòϸ°û¿ÉÓÃÔÚÌÇÄò²¡ÖÜΧ¾«Éñ²¡±äµÄ¼²²¡½¨Ä£¼°Ò©ÎïÑз¢
ÈÕÆÚ£º2023-05-25 À´Àú£º±¾Õ¾ ¹©¸å£ºÒ½Ò©ÉúÎï¼¼ÄÜ´¦ ×÷ÕߣºÖÎÀíÔ± ÖÖ±ð£ºÒëÎÄ
Ê©Íòϸ°û£¨Schwann cells£¬SC£©ÊÇÖÜΧÉñ¾ÌåϵÖÐÖØÒªµÄ½ºÖÊϸ°û¡£SCÓëºÜ¶à¼²²¡Óйأ¬ÌÇÄò²¡ÖÜΧ¾«Éñ²¡±ä£¨DÓÀººÕòÔÆ¶¥¼¯ÍÅ-iabeticperipheral neuropathy£¬DPN£©ÊÇ´ËÖÐÖ®Ò»¡£ÃÀ¹ú¼ÓÖÝÄêҹѧ¾É½ðɽ·ÖУÑо¿Ö°Ô±·¢Ã÷£¬È˶àÄܸÉϸ°û£¨human pluripotent stem cell£¬hPSC£©ÑÜÉúµÄÊ©Íòϸ°û¿ÉÓÃÔÚÌÇÄò²¡ÖÜΧ¾«Éñ²¡±äµÄ¼²²¡½¨Ä£¼°Ò©ÎïÑз¢¡£¸ÃÑо¿½á¹ûÔÚ½üÈÕ·¢±íÓÚ¡¶Cell Stem Cell¡·ÔÓÖ¾ÉÏ£¬ÌâΪ£ºDeriving Schwann cells fromhPSCs enables disease modeling and drug discovery for diabetic peripheralneuropathy¡£ Ñо¿Ö°Ô±Õ¹ÏÖÁËÒ»ÖÖ´ÓhPSCÑÜÉúSCµÄ¼ÆÄ±£¬´Ó¶ø¿ÉÒÔ»òÐíÖÜÈ«Ñо¿SCµÄ·¢Óý¡¢ÐÄÀíºÍÓë¼²²¡µÄ¹Ï¸ð¡£hPSCÑÜÉúµÄSCÔÙÏÖÁËÔ´úSCµÄ·Ý×ÓÌØÐÔ£¬²¢¿ÉÒÔ»òÐíÓÚÌåÍâ¼°ÌåÄÚ¾ÙÐÐËèÇÊ»¯¡£ËûÃdzÉÁ¢ÁËÒ»¸öDPNÄ£×Ó£¬ÏÔʾSC¶ÔÓÚ¸ßѪÌǾ߱¸Ñ¡ÔñÒ×ËðÐÔ¡£ËûÃǾÓɹý³Ì¸ßͨÁ¿É¸Ñ¡·¢Ã÷£¬¿¹ÒÖÓôÒ©Îï°²·ÇËûͪÄܵÖÏûSCÖÐÆÏÌÑÌǵ;ÐÔ¡£Óð²·ÇËûͪҽÖθßѪÌǵÄСÊó¿ÉÒÔ±ÜÃâ¾õµÃ¹¦Ð§Õϰ¡¢SCÃðÍö¼°ËèÇÊ»ÙÉË¡£ ×ÛÉÏ£¬hPSCÑÜÉúµÄÊ©Íòϸ°ûΪɸѡDPNµÄÒ½Öη½°¸ÌṩÁË¿Éѡģ×Ó¼°Ñо¿¶ÔÓÚÏó¡£ ×¢£º´ËÑо¿½á¹ûÕª×Ô¡¶Cell Stem Cell¡·ÔÓÖ¾£¬ÎÄÕÂÄÚÈݲ»´ú±í±¾ÍøÕ¾²»Ñŵ㼰̬¶È£¬½ö¹©²Î¿¼¡£-ÓÀººÕòÔÆ¶¥¼¯ÍÅ-